GlobeNewswire by notified

Philips and Vanderbilt University Medical Center unite to define roadmap for decarbonizing radiology

Share

May 22, 2023

Amsterdam, the Netherlands and Nashville, TN, USARoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Vanderbilt University Medical Center (VUMC), home to the top-ranked adult and pediatric hospitals in the Southeastern U.S., today announced a collaboration that aims to reduce the health system’s carbon footprint while determining a blueprint to guide industry efforts. The project is with the radiology department, where efforts will focus on measuring and addressing energy consumption of VUMC’s diagnostic imaging devices including MR, CT, ultrasound and X-ray. The two organizations plan to publish their findings with the aim of promoting knowledge exchange and enabling others in the industry to enhance their environmental strategies.

The healthcare industry is responsible for an estimated 7.6% of U.S. and 4.4% of global emissions [1]; with its heavy energy, equipment, and supply usage, radiology is a significant contributor to the CO2 emissions responsible for climate change [2]. Philips will work with VUMC to collect a range of equipment lifecycle data, including radiology data and measurements of the equipment energy consumption, analyze operational workflow efficiency and interview VUMC staff and faculty to build computational models on which to run simulations. The teams will then summarize piloted interventions to test the reduction of the department’s carbon footprint.

“We consider climate care as healthcare. Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity, it’s also a responsibility. The future of radiology requires us to be cognizant, aware and proactive about addressing this issue which directly affects the communities we live in and the patients we treat,” said Reed Omary, MD, MS, Carol D. and Henry P. Pendergrass Professor and Chair of Radiology at Vanderbilt University Medical Center. “We have a collective responsibility to help mitigate climate change, which is why we’ve entered into this collaboration. Working together will allow us to leverage Philips’ general healthcare and specific radiology expertise – as well as their own success in achieving CO2 net-zero operations – to make important reductions in our carbon footprint.”

In addition to financial costs for a given diagnosis, VUMC’s Department of Radiology and Radiological Sciences understands that there is also an additional carbon cost to make that diagnosis. Philips brings knowledge and a longstanding commitment to sustainability to the collaboration. Recently, Philips became the first health technology company to have its entire value-chain CO₂ emissions reduction targets approved by the Science Based Targets initiative (SBTi) with strategic action plans in place. The company has reported solid progress in reducing CO2 emissions across its innovations and supply chain, and has operated globally carbon neutral since 2020. Philips builds on decades of experience reducing energy consumption, waste, and materials and substances usage by embedding its EcoDesign criteria and circular business models across product innovation and ways of working. Through digitalization and collaboration, the company actively seeks to expand access to care, while working closely with customers and partners to improve the environmental impact of in-use diagnostic imaging technology.

“Philips and VUMC share a common vision – that systemically addressing climate change is going to take commitment and collaboration across the industry. Philips’ 2023 Future Health Index found that nearly half of U.S. healthcare leaders are planning to overcome challenges to implementing sustainability initiatives by sharing best practices and learnings from peers,” said Jeff DiLullo, chief region leader, Philips North America. “We are optimistic that results from this partnership will not only assist Vanderbilt in its effort to understand and address carbon emissions in its own radiology department, but serve as a model for others seeking to decarbonize their operations.”

[1] https://noharm-global.org/sites/default/files/documents-files/5961/HealthCaresClimateFootprint_092319.pdf
[2] https://www.researchgate.net/publication/366649243_Climate_Change_Carbon_Dioxide_Emissions_and_Medical_Imaging_Contribution

For further information, please contact:

Avi Dines

Philips North America
Tel: + 1 781 690 3814
Email: avi.dines@philips.com

Mark Groves
Philips Global Press Office
Tel: +31 631 639 916
Email: mark.groves@philips.com

Vanderbilt Radiology Communications (please contact both):
Derek Scancarelli
Senior Communications Specialist
derek.scancarelli@vumc.org

Jackson Hicks
Associate Communications Specialist
Jackson.hicks@vumc.org

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 74,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

About Vanderbilt University Medical Center
Vanderbilt University Medical Center (VUMC) is the largest comprehensive research, teaching and patient care health system in the Mid-South region, with the highest ranked adult and children’s hospitals in the Southeast by U.S. News & World Report. Based in Nashville, Tennessee, VUMC sees over 3 million patient visits per year in over 200 ambulatory locations, performs 88,000 surgical operations and discharges 80,000 inpatients from its main-campus adult, children’s, psychiatric and rehabilitation hospitals and three regional community hospitals. The Medical Center is the largest non-governmental employer of Middle Tennesseans, with nearly 40,000 staff, including more than 3,000 physicians, advanced practice nurses and scientists appointed to the Vanderbilt University faculty. For more information and the latest news follow VUMC on FacebookLinkedInTwitter and in the VUMC Reporter.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Subsea 7 S.A. notification of major holding3.5.2024 18:32:01 CEST | Press release

Luxembourg –3 May 2024 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced that, on 3 May 2024, Barclays Capital Securities Limited1 informed the Company that it had breached thresholds provided for by Luxembourg’s Transparency Law of 11 January 2008 on transparency requirements for issuers of securities as amended (the “Transparency Law”) as follows: On 30 April 2024 the total number of voting rights in the Company according to Article 8 and 9 of the Transparency Law attached to shares was 1,044,272 On 30 April 2024 the total number of voting rights in the Company attached to financial instruments with similar economic effect according to Article 12 (1) (a) of the Transparency Law (right to recall) was 13,906,019On 30 April 2024 the total number of voting rights in the Company attached to financial instruments with similar economic effect according to Article 12 (1) (b) of the Transparency Law (swaps) was 499,740 When combined, the above positions equate to 5.07% of voting r

NGS Group AB: NGS Group offentliggör utfall i riktad emission om 16,1 MSEK3.5.2024 18:00:00 CEST | Pressemelding

NGS Group AB:s (publ) (”NGS Group” eller ”Bolaget”) nyemission av aktier riktad till strategiska investerare om cirka 16,1 MSEK, före emissionskostnader (den ”Riktade Emissionen”) som beslutades av styrelsen den 29 februari 2024 och godkändes av den extra bolagsstämman den 26 mars 2024, har tecknats med totalt 4 962 577 aktier. Genom den Riktade Emissionen tillförs Bolaget cirka 16,1 MSEK, före avdrag för emissionskostnader. Utfall i den Riktade Emissionen Hugo Lewné och Nils Sjögren har tecknat och tilldelats totalt 4 962 577 aktier motsvarande cirka 16,1 MSEK i den Riktade Emissionen. Storleken på den Riktade Emissionen styrdes av teckningsgraden i den nyemission av aktier med företrädesrätt för befintliga aktieägare om ca 35,2 MSEK, före emissionskostnader (”Företrädesemissionen” och tillsammans med den Riktade Emissionen ”Emissionerna”) vari slutligt utfall offentliggjordes den 29 april 2024. Då Företrädesemissionen övertecknades innebär det att den Riktade Emissionens omfattning ä

Bulletin from BTS Group AB's Annual General Meeting3.5.2024 17:34:40 CEST | Press release

Stockholm May 3, 2024 The Annual General Meeting approved the proposed dividend to shareholders of SEK 5,70 per share, divided into two payment occasions of SEK 2,85 each. The record date for the first payment of SEK 2,85 was determined to Tuesday May 7, 2024 and for the second payment of SEK 2,85 was determined to Wednesday November 13, 2024. The first payment is expected to be made on Monday May 13, 2024 and the second payment is expected to be made on Monday November 18, 2024. The Annual General Meeting discharged the members of the Board of Directors and the CEO from liability for the financial year 2023 and approved the remuneration report for 2023 prepared by the Board of Directors. The Annual General Meeting approved the remuneration to board members to a total of SEK 1,735,000, of which SEK 525,000 to the Chairman and SEK 235,000 to each of the other board members, and SEK 60,000 to the Deputy Board member. A total fee of SEK 225,000 shall be paid for committee work. Mariana Bu

Kommuniké från BTS Group ABs årsstämma3.5.2024 17:34:40 CEST | Pressemelding

Stockholm 3 maj 2024 Årsstämman fastställde föreslagen utdelning till aktieägarna om 5,70 kronor per aktie, uppdelat på två utbetalningstillfällen om vardera 2,85 SEK. Som avstämningsdag för den första utbetalningen om 2,85 SEK fastställdes tisdagen den 7 maj 2024 och för den andra utbetalningen om 2,85 SEK fastställdes onsdagen den 13 november 2024. Den första utbetalningen beräknas ske måndagen den 13 maj 2024 och den andra utbetalningen beräknas ske måndagen den 18 november 2024. Årsstämman beviljade styrelseledamöterna och verkställande direktören ansvarsfrihet för verksamhetsåret 2023 samt godkände den av styrelsen upprättade ersättningsrapporten för 2023. Årsstämman fastställde arvodet till styrelseledamöter till totalt 1 735 000 kronor, varav 525 000 kronor till ordföranden och 235 000 kronor till respektive övrig styrelseledamot, samt 60 000 kronor till styrelsesuppleanten. För utskottsarbete skall ett totalt arvode om 225 000 kronor utgå. Mariana Burenstam Linder, Stefan Garde

Wistar Scientists Discover New Immunosuppressive Mechanism in Brain Cancer3.5.2024 17:32:16 CEST | Press release

Wistar’s Veglia lab identified how glioblastoma evades the immune system by inducing pro-tumor macrophages via a glucose based epigenetic modification. PHILADELPHIA, PA, May 03, 2024 (GLOBE NEWSWIRE) -- The Wistar Instituteassistant professor Filippo Veglia, Ph.D., and team, have discovered a key mechanism of how glioblastoma — a serious and often fatal brain cancer — suppresses the immune system so that the tumor can grow unimpeded by the body’s defenses. The lab’s discovery was published in the paper, “Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma,” in the journal Immunity. “Our study shows that the cellular mechanisms of cancer’s self-preservation, when sufficiently understood, can be used against the disease very effectively,” said Dr. Veglia. “I look forward to future research on metabolism-driven mechanisms of immunosuppression in glioblastoma, and I’m hopeful for all that we will continue to learn about

HiddenA line styled icon from Orion Icon Library.Eye